Library Open Repository

Lumiracoxib (Novartis)

Downloads

Downloads per month over past year

Ding, C and Jones, G (2002) Lumiracoxib (Novartis). IDrugs, 5 (12). pp. 1168-1172. ISSN 1369-7056

[img]
Preview
PDF
lumiracoxib.pdf | Download (98kB)
Available under University of Tasmania Standard License.

Abstract

Lumiracoxib, an inhibitor of cyclooxygenase 2 (COX-2), is under development by Novartis for the potential treatment of osteoarthritis, rheumatoid arthritis and pain. By late December 2000, phase III trials had been initiated and were ongoing in December 2001.

Item Type: Article
Journal or Publication Title: IDrugs
Page Range: pp. 1168-1172
ISSN: 1369-7056
Date Deposited: 14 Mar 2008 00:23
Last Modified: 18 Nov 2014 03:31
URI: http://eprints.utas.edu.au/id/eprint/3523
Item Statistics: View statistics for this item

Repository Staff Only (login required)

Item Control Page Item Control Page